A study to know the effects of magnesiun sulphate and fentanyl in spinal anesthesia.
Not Applicable
- Conditions
- Health Condition 1: K929- Disease of digestive system, unspecified
- Registration Number
- CTRI/2022/03/041477
- Lead Sponsor
- Mayo institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Consent for participation in the study
Both sex
Age 18 to 55 years
ASA grade 1 and 11
Infraumbilical surgeries.
Exclusion Criteria
Refusal for participation in the study
ASA Grade above III
History of any drug allergies
Opioid addicts
Anatomical spinal deformities/malformations
Any chronic comorbidity
Any acute URTI or fever
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain magnesium sulfate's adjuvant role in spinal anesthesia with bupivacaine for digestive system surgeries?
How does subarachnoid magnesium sulfate compare to fentanyl in prolonging postoperative analgesia with 0.5% heavy bupivacaine for infraumbilical procedures?
What biomarkers predict analgesic efficacy of magnesium sulfate or fentanyl as spinal adjuvants in CTRI/2022/03/041477 trial for K929- digestive system disease?
What adverse events are associated with magnesium sulfate and fentanyl as spinal adjuvants in Mayo Institute's CTRI/2022/03/041477 trial for digestive system surgeries?
What alternative adjuvants to fentanyl and magnesium sulfate are being evaluated with bupivacaine for postoperative pain management in abdominal surgeries?